Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
La inmunoterapia es ya una realidad para algunos tumores. En otros se avanza para reemplazar a técnicas más agresivas, pero todavía tendrán que convivir con las más modernas durante años 
No comment yet.
Sign up to comment
Scoop.it!
Forbes
Alfredo Corell's insight:
It’s hard to keep track of practice-changing drugs for chronic lymphocytic leukemia (CLL). Since last November, the FDA has approved three new agents and expanded indications for another to treat this indolent cancer of white blood cells. As someone who spent over ten years studying this form of leukemia, I’m thrilled by the science behind these targeted medicines, and by the potentially life-saving new options for people with this condition.
|
Scoop.it!
Dan Chen MD, PhD from Stanford Medical Oncology and Genentech describes brilliantly how our immune system detects cancer cells and how tumors get past our im...
Alfredo Corell's insight:
An awesome, simple and understandable animation about the use of PD-1 and PD-L1 interactions in cancer immunotherapy. A must see!!! Brilliant way to understand the effects of checkpoint inhibitors and cancer immunotherapy.
|
La inmunoterapia se está configurando como una terapia individualizada en la lucha contra muchos tumores. Ya no es ciencia-ficción... las defensas nos ayudan a eliminar tumores. Este ha sido el lema principal de Congreso mundial de Inmunología que se ha celebrado en Melbourne en agosto de 2016